未登录.png)
分享.png)
收藏分享 收藏 Efficacy and safety of consolidative thoracic radiotherapy after first-line chemoimmunotherapy in patients with extensive-stage small-cell lung cancer: a retrospective cohort study
Zheng, Lin; Yang, Yang; Bu, Fan; Ye, Ruizhi; Zhang, Fengming; Ji, Zhixiang; Zhu, Xirong; Chen, Hong; Shao, Rongjun; Liu, Lidan; Ying, Xixi; Zhu, Lingying; Wang, Enyu; Feng, Jifeng; Shi, Zhiyong; Fang, Jun; Wang, Yuezhen; Zhou, Zhirui; You, Guangxian 分享 收藏 CHRONOS-4: phase 3 study of copanlisib plus rituximab-based immunochemotherapy in relapsed indolent B-cell lymphomaCHRONOS-4: copanlisib加利妥昔单抗为基础的免疫化疗治疗复发性惰性b细胞淋巴瘤的3期研究Zinzani, Pier Luigi; Wang, Huaqing; Feng, Jifeng; Kim, Tae Min; Tao, Rong; Zhang, Huilai; Fogliatto, Laura; Artigal, Clara Maluquer; Ozcan, Muhit; Yanez, Eduardo; Kim, Won Seog; Kirtbaya, Dmitry; Kriachok, Iryna; Maciel, Felipe; Xue, Hongwei; Bouabdallah, Krimo; Phelps, Charles; Chaturvedi, Shalini; Weispfenning, Anke; Morcos, Peter N.; Odongo, Fatuma; Buvaylo, Viktoriya; Childs, Barrett H.; Dreyling, Martin; Matasar, Matthew; Ghione, Paola 分享 收藏 Ivonescimab Plus Chemotherapy in Non-Small Cell Lung Cancer With EGFR Variant A Randomized Clinical TrialIvonescimab联合化疗治疗EGFR变异的非小细胞肺癌随机临床试验Fang, Wenfeng; Zhao, Yuanyuan; Luo, Yongzhong; Yang, Runxiang; Huang, Yan; He, Zhiyong; Zhao, Hui; Li, Mingjun; Li, Kai; Song, Qibing; Du, Xiaobo; Sun, Yulan; Li, Wei; Xu, Fei; Wang, Zhiyu; Yang, Kunning; Fan, Yun; Liu, Baogang; Zhao, Hongyun; Hu, Ying; Jia, Li; Xu, Shen; Yi, Tienan; Lv, Dongqing; Lan, Haitao; Li, Mengxia; Liang, Wenhua; Wang, Yongsheng; Yang, Hui; Jia, Yuming; Chen, Yuan; Lu, Junguo; Feng, Jifeng; Liu, Chunling; Zhou, Ming; Zhou, Jianya; Liu, Xianling; Zhou, Ningning; He, Ming; Dong, Xiaorong; Chen, Hualin; Chen, Yongxing; Su, Haichuan; Li, Xiaoling; Zhang, Zhihong; Yang, Lei; Cheng, Ying; Chen, Likun; Hou, Xue; Zhang, Yu; Guo, Jun; Wang, Zhen; Lu, Hong; Wu, Di; Feng, Weineng; Li, Wen; Huang, Jianan; Wang, Yan; Song, Xia; Peng, Jiewen; Liu, Laiyu; Guo, Yubiao; Li, Wenting; Lu, Dongmei; Hu, Mingxiu; Wang, Zhongmin Maxwell; Li, Baiyong; Xia, Michelle; Zhang, Li 分享 收藏 Disitamab vedotin, a HER2-directed antibody-drug conjugate, in patients with HER2-overexpression and HER2-low advanced breast cancer: a phase I/Ib studyHER2-overexpression和HER2-low晚期乳腺癌患者的HER2-directed抗体药物偶联物Disitamab vedotin: I/Ib期研究Wang, Jiayu; Liu, Yunjiang; Zhang, Qingyuan; Li, Wei; Feng, Jifeng; Wang, Xiaojia; Fang, Jianmin; Han, Yiqun; Xu, Binghe 分享 收藏 Safety profiles of Chinese breast cancer patients who received abemaciclib in MONARCH plus and monarchE studyShao, Zhimin; Zhang, Qingyuan; Ouyang, Quchang; Liu, Qiang; Feng, Jifeng; Li, Hui-Ping; Wang, Xiaojia; Liao, Ning; Yang, Liu; Zhu, Qinyi; Qian, Chenxi; Jiang, Zefei 分享 收藏 Open-label, single-arm, multicenter, phase 2 trial of garsorasib in KRAS G12C-mutated non-small-cell lung cancerLi, Ziming; Dang, Xiaomin; Huang, Dingzhi; Jin, Shi; Li, Weiwei; Shi, Jianhua; Wang, Xicheng; Zhang, Yiping; Song, Zhengbo; Zhang, Junping; Zhuang, Wu; Liu, Xuewen; Jiang, Liyan; Meng, Xiangjiao; Zhao, Mingfang; Zhou, Jianying; Zhang, Liangming; Wang, Pingli; Luo, Hui; Yang, Junquan; Cang, Shundong; Wang, Xiang; Wang, Jing; Cui, Jiuwei; Yu, Yan; Zhang, Zhihong; Lu, Junguo; Yang, Weihua; Li, Gaofeng; Feng, Jifeng; Lv, Dongqing; Wu, Lin; Fang, Yong; Wang, Yan; Zhao, Yanqiu; Cao, Baoshan; Zhu, Wei; Zhuang, Zhixiang; Li, Qingshan; Wang, Mingxi; Zhou, Huan; Dong, Xiaorong; Hu, Sheng; Fang, Jian; Zhang, Yihong; Wang, Wenjia; Xiang, Ziyong; Shi, Zhe; Zhang, Ling; Lu, Shun 分享 收藏 CircRNA G6PC3 promotes lung adenocarcinoma progression through enhancing HMGB1/Beclin 1 complex to induce autophagyPan, Banzhou; Huang, Jiayuan; Feng, Bing; Shen, Bo; Lu, Jianwei; Wu, Yuan; Li, Chenchen; Chen, Chen; Feng, Jifeng; Xu, Yong; Wang, Xiaohua 分享 收藏 Optimal response to tislelizumab plus chemotherapy in metastatic triple-negative breast cancer: a case report and literature reviewtislelizumab联合化疗治疗转移性三阴性乳腺癌的最佳反应: 病例报告和文献复习Ma, Yuxin; Shi, Xinhong; Zhao, Kun; Hu, Shuyi; Shi, Yue; Jiang, Yingying; Liu, Yiling; Lu, Lin; Chang, Yuting; Zhou, Fei; Dai, Yingying; Wu, Zipeng; Li, Shiyi; Qian, Zhiying; Xu, Xia; Li, Chenchen; Shen, Bo; Zhou, Guoren; Chen, Cheng; Wang, Xiaohua; Feng, Jifeng 分享 收藏 Rolapitant treats lung cancer by targeting deubiquitinase OTUD3Du, Tongde; Gu, Quan; Zhang, Yonghui; Gan, Yujie; Liang, Rongrui; Yang, Wenzhu; Lu, Ya; Xu, Chenxin; Wu, Jianzhong; Ma, Rong; Cao, Haixia; Jiang, Jingwei; Wang, Juan; Feng, Jifeng 分享 收藏 A real-world observation on thrombopoietic agents for patients with cancer treatment-induced thrombocytopenia in China: A multicenter, cross-sectional studyChen, Meiting; Li, Lu; Xia, Qing; Chen, Xiaobing; Liao, Zijun; Wang, Chang; Shen, Bo; Zhou, Min; Zhang, Qingyuan; Zhang, Yanqiao; Qian, Liting; Yuan, Xianglin; Wang, Zhehai; Xue, Cong; An, Xin; Liu, Bin; Gu, Kangsheng; Hou, Mei; Wang, Xiaojia; Wang, Wei; Li, Enxiao; Zhong, Jincai; Cheng, Jing; Shu, Yongqian; Yang, Nong; Wang, Huaqing; Yang, Runxiang; Liu, Tianshu; Deng, Ting; Ma, Fei; Liao, Wangjun; Qiu, Wensheng; Chen, Yu; Chen, Xi; Zhang, Mingzhi; Xu, Ruilian; Li, Xiaoling; Feng, Jifeng; Ba, Yi; Shi, Yanxia 分享 收藏 Updated overall survival and circulating tumor DNA analysis of ensartinib for crizotinib-refractory ALK-positive NSCLC from a phase II studyZheng, Jing; Wang, Tao; Yang, Yunpeng; Huang, Jie; Feng, Jifeng; Zhuang, Wu; Chen, Jianhua; Zhao, Jun; Zhong, Wei; Zhao, Yanqiu; Zhang, Yiping; Song, Yong; Hu, Yi; Yu, Zhuang; Gong, Youling; Chen, Yuan; Ye, Feng; Zhang, Shucai; Cao, Lejie; Fan, Yun; Wu, Gang; Guo, Yubiao; Zhou, Chengzhi; Ma, Kewei; Fang, Jian; Feng, Weineng; Liu, Yunpeng; Zheng, Zhendong; Li, Gaofeng; Wang, Huijie; Cang, Shundong; Wu, Ning; Song, Wei; Liu, Xiaoqing; Zhao, Shijun; Ding, Lieming; Selvaggi, Giovanni; Wang, Yang; Xiao, Shanshan; Wang, Qian; Shen, Zhilin; Zhou, Jianya; Zhou, Jianying; Zhang, Li 分享 收藏 Long-term outcomes with HLX01 (HanliKang®), a rituximab biosimilar, in previously untreated patients with diffuse large B-cell lymphoma: 5-year follow-up results of the phase 3 HLX01-NHL03 studyQin, Yan; Song, Yongping; Wang, Dong; Bai, Ou; Feng, Jifeng; Sun, Xiuhua; Qiu, Lihua; Yang, Jianmin; Yang, Yu; Wang, Zhao; Hu, Jianda; Wang, Huaqing; Su, Hang; Jin, Zhengming; Qian, Wenbin; Jin, Chuan; Zhang, Mingzhi; Yu, Ding; Liu, Li; Chen, Guoan; Li, Yarong; Sun, Tao; Jin, Jie; Bao, Huizheng; Du, Xin; Zhou, Hui; Fu, Gan; Shi, Yuankai 分享 收藏 分享 收藏 Therapeutic effectiveness of anlotinib combined with etoposide in extensive-stage small-cell lung cancer: a single-arm, phase II trial安洛替尼联合依托泊苷治疗广泛期小细胞肺癌的疗效: 一项单臂II期试验Wu, Yuan; Zhou, Xuefeng; Zhao, Weiqing; Wang, Qiong; Han, Zhengxiang; Wang, Lifeng; Zhou, Wenjie; Zhou, Tong; Song, Haizhu; Chen, Yong; Yang, Kaihua; Shi, Lin; Pan, Banzhou; Guo, Renhong; Zhou, Guoren; Jiang, Feng; Feng, Jifeng; Shen, Bo 分享 收藏 CLASRP oncogene as a novel target for colorectal cancerCLASRP癌基因作为结直肠癌的新靶点Gu, Quan; Wu, Jianzhong; Xu, Heng; Cao, Haixia; Zhang, Junying; Jing, Changwen; Wang, Zhuo; Du, Mengjie; Ma, Rong; Feng, Jifeng 分享 收藏 PDE4D/cAMP/IL-23 axis determines the immunotherapy efficacy of lung adenocarcinoma via activating the IL-9 autocrine loop of cytotoxic T lymphocytesFeng, Bing; Pan, Banzhou; Huang, Jiayuan; Du, Yuxin; Wang, Xin; Wu, Jianzhong; Ma, Rong; Shen, Bo; Huang, Guichun; Feng, Jifeng 分享 收藏 Entinostat, a class I selective histone deacetylase inhibitor, plus exemestane for Chinese patients with hormone receptor-positive advanced breast cancer: A multicenter, randomized, double- blind, placebo-controlled, phase 3 trialXu, Binghe; Zhang, Qingyuan; Hu, Xichun; Li, Qing; Sun, Tao; Li, Wei; Ouyang, Quchang; Wang, Jingfen; Tong, Zhongsheng; Yan, Min; Li, Huiping; Zeng, Xiaohua; Shan, Changping; Wang, Xian; Yan, Xi; Zhang, Jian; Zhang, Yue; Wang, Jiani; Zhang, Liang; Lin, Ying; Feng, Jifeng; Chen, Qianjun; Huang, Jian; Zhang, Lu; Yang, Lisong; Tian, Ying; Shang, Hongyan 分享 收藏 Clinical efficacy of fulvestrant versus exemestane as first-line therapies for Chinese postmenopausal oestrogen-receptor positive/human epidermal growth factor receptor 2-advanced breast cancer (FRIEND study)氟维司坦与依西美坦一线治疗中国绝经后雌激素受体阳性/人表皮生长因子受体2-晚期乳腺癌的临床疗效 (FRIEND研究)Wang, Jiayu; Cai, Li; Song, Yanqiu; Sun, Tao; Tong, Zhongsheng; Teng, Yuee; Li, Huiping; Ouyang, Quchang; Chen, Qianjun; Cui, Shude; Yin, Yongmei; Liao, Ning; Sun, Qiang; Feng, Jifeng; Wang, Xiaojia; Xu, Binghe 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
